Wearable devices supporting the continuous monitoring of glucose in dermal-interstitial fluid have transformed the management of diabetes. This singular, but major, success in the high-frequency measurement of a molecular biomarker has inspired broader pursuit of biosensors supporting similarly real-time, high-frequency measurements of markers indicative of the numerous other disease and health conditions that could benefit from continuous monitoring.